Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00599989 · ClinicalTrials.gov registry record · NA
Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT00599989 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 28 participants.
The verdict
NCT00599989, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. PURPOSE: This clinical trial is studying the side effects of partial breast radiation therapy and how well it works in treating women undergoing breast conservation therapy for early-stage breast cancer.
Interventions
- PROCEDURE conventional surgery
- RADIATION brachytherapy
- RADIATION 3-dimensional conformal radiation therapy
- PROCEDURE adjuvant therapy
- RADIATION intracavitary balloon brachytherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2005-01 |
| Est. Completion | 2009-05-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00599989
The ClinicalTrials.gov registry entry for NCT00599989 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which conventional surgery is the first listed.
NCT00599989 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00599989 about?
NCT00599989 is a clinical study titled "Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer". RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. PURPOSE: This clinical trial is studying the side effects of partial breast radiation therapy and how well it works in treating women undergoing breast conservation therapy for early-stage breast cancer.
What is the current status of trial NCT00599989?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2005-01. Estimated completion is 2009-05-11.
What interventions are being tested in trial NCT00599989?
The interventions under investigation include: conventional surgery (PROCEDURE), brachytherapy (RADIATION), 3-dimensional conformal radiation therapy (RADIATION), adjuvant therapy (PROCEDURE), intracavitary balloon brachytherapy (RADIATION).
Who is sponsoring clinical trial NCT00599989?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.